From: Determinants of mortality in non-neutropenic ICU patients with candidaemia
Variable | Dying patients, n (%) | Surviving patients, n (%) | Univariate analysis* | Multivariate analysis** | ||
---|---|---|---|---|---|---|
Unadjusted HR (95% CI) | P | Adjusted HR (95% CI) | P | |||
Age | 1.03 (1.01 to 1.05) | 0.001 | 1.03 (1.01 to 1.05) | 0.002 | ||
Haemodialysis receipt | 10/48 (21%) | 4/45 (9%) | 1.65 (0.82 to 3.32) | 0.16 | 2.12 (1.03 to 4.35) | 0.04 |
TPN receipt | 30/48 (63%) | 15/45 (33%) | 1.90 (1.06 to 3.42) | 0.03 | ||
Non-multitrauma patient | 47/48 (98%) | 33/45 (73%) | 9.35 (1.29 to 67.84) | 0.03 | ||
Ventilation day 1 | 40/48 (83%) | 34/45 (76%) | 1.28 (0.60 to 2.75) | 0.52 | ||
Candida glabrata or Candida krusei | 11/48 (23%) | 3/45 (7%) | 2.31 (1.17 to 4.56) | 0.02 | ||
Time to fluconazole initiation | 1.80 ± 1.29 days | 2.51 ± 1.74 days | 0.80 (0.65 to 0.98) | 0.03 | ||
Fluconazole MIC (log10 transformed) | 0.24 ± 0.74 | 0.10 ± 0.68 | 1.31 (0.90 to 1.90) | 0.16 | ||
Fluconazole dose (log10 transformed) | 2.66 ± 0.22 | 2.62 ± 0.21 | 1.89 (0.52 to 6.82) | 0.33 | ||
Fluconazole dose: MIC (log10 transformed) | 2.33 ± 0.22 | 2.45 ± 0.72 | 0.77 (0.54 to 1.11) | 0.16 |